Company profile

Envisionit DeepAI Ltd

Medical Imaging & Radiology

Company profile

About Envisionit DeepAI Ltd

Envisionit Deep AI is a UK-based health AI company that addresses critical gaps in medical AI validation and monitoring through its flagship product, RATIFY. The company was founded by Dr. Jaishree Naidoo, a radiologist who recognized that while AI tools performed well in trials, they often behaved unpredictably once deployed in real-world clinical settings. RATIFY is an independent, vendor-agnostic AI assurance platform specifically designed for radiology that provides real-time validation, continuous performance monitoring, drift detection, and human-AI interaction tracking. The platform integrates directly into existing PACS/RIS workflows, operating autonomously in the background without requiring additional clicks from clinicians. By delivering transparent, accountable, and measurable AI performance data, RATIFY helps healthcare providers reduce medico-legal risk from AI misdiagnosis, demonstrate clear ROI on AI investments, eliminate manual quality assurance burdens, and gain insight into bias and model drift. The company's vision is to set the global standard for independent monitoring and assurance of medical AI, ensuring every patient benefits from AI they can trust. Envisionit Deep AI serves hospitals, health systems, and radiology departments seeking to deploy AI tools safely and effectively while maintaining full compliance with EU and FDA standards.

Company description Envisionit DeepAI Ltd official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Envisionit DeepAI Ltd?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • General radiology imaging conditions
  • Pneumonia
  • Tuberculosis

Who it serves

  • Health Systems
  • Healthcare Providers
  • Hospitals
  • Radiology Departments

Deployment & integration

Hybrid · Other deployment with recorded integration context.

Recorded integration context: PACS, RIS.

Geographic context

MarketsGlobal expansion planned · South Africa · United Kingdom
Company sourceOfficial website

Company milestones

Platform expansion

Featured on Nasdaq (September 2024); Featured on CNN (August 2024); Keynote speaker at ECR 2025 Vienna (March 2025); Partnership with Bayer announced at RSNA 2024; Sifted Summit London speaker (October 2024); Received Transformative Tech grant from Innovate UK; Expanding RATIFY into other medical imaging modalities; Raising capital for global market reach

Partnerships

Recorded partners

  • Bayer (collaboration announced at RSNA 2024)
  • Innovate UK
  • UK-South African Tech Hub

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

BUILD AI

AI development solution for healthcare diagnostics

Platform · OtherCompany source

RATIFY

Independent AI assurance platform for radiology delivering real-time validation, monitoring, and drift detection

Platform · HybridCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

No linked records are currently available.

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

Radify Triage

K231871 · 510k · Jan 17, 2024

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Reduced diagnostic errors

Real-time independent assurance without disrupting workflows

Reduced medico-legal risk

From AI misdiagnosis through continuous monitoring

Clear ROI demonstration

On AI investments through performance data

Eliminated manual QA burden

Autonomous monitoring replacing manual quality assurance

Bayer

Collaboration on AI-enabled applications for radiology at RSNA 2024

Partnership advancing healthcare through AI for better outcomes for patients and physicians

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Dr. Jaishree Naidoo

Dr. Jaishree Naidoo

Radiologist, Co-Founder & CEO

LinkedIn
Terence Naidu

Terence Naidu

Business Development & Co-Founder

LinkedIn

Andrei Migatchev

Chief Technology Officer & Co-Founder

06 · Company updates

Updates from Envisionit DeepAI Ltd

Recent articles published on Envisionit DeepAI Ltd's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon